Immediate Impact
57 standout
Citing Papers
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of C Singer being referenced
165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| C Singer | 122 | 52 | 80 | 94 | 91 | 14 | 304 | |
| Marie Stenmark Askmalm | 146 | 26 | 132 | 137 | 108 | 14 | 360 | |
| Ian Laidlaw | 179 | 28 | 55 | 108 | 114 | 12 | 346 | |
| R.A.E.M. Tollenaar | 161 | 58 | 43 | 54 | 76 | 22 | 337 | |
| So Young Kang | 128 | 33 | 86 | 181 | 133 | 12 | 346 | |
| Han-Sung Kang | 141 | 35 | 64 | 141 | 77 | 18 | 287 | |
| Ryosuke Hayami | 101 | 13 | 54 | 69 | 252 | 20 | 363 | |
| Samuel J Haryono | 88 | 17 | 20 | 70 | 85 | 17 | 254 | |
| T. S. Ravikumar | 108 | 73 | 57 | 29 | 179 | 14 | 362 | |
| Ye-Young Rhee | 212 | 75 | 56 | 61 | 107 | 15 | 339 | |
| Rebecca P. M. Brosens | 176 | 37 | 75 | 98 | 90 | 10 | 322 |
All Works
Loading papers...